1. Catecholaminergic Crisis After a Bleeding Complication of COVID-19 Infection: A Case Report
- Author
-
Yiraldine Herrera-Martínez, María J. Molina-Puertas, Concepcion Munoz-Jimenez, Aura D. Herrera-Martínez, María A Gálvez-Moreno, Rosa Ortega-Salas, Maria Rosa Alhambra-Exposito, F. Leiva-Cepas, Carlos Alzas, and Angel Rebollo-Roman
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,COVID19 ,Endocrinology, Diabetes and Metabolism ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Adrenal Gland Neoplasm ,Adrenal Gland Neoplasms ,Hemorrhage ,Case Report ,complication ,Pheochromocytoma ,Diseases of the endocrine glands. Clinical endocrinology ,Endocrinology ,Palpitations ,Humans ,Medicine ,Catecholaminergic ,business.industry ,COVID-19 ,Pneumonia ,Middle Aged ,medicine.disease ,RC648-665 ,bleeding ,pheochromocytoma ,medicine.symptom ,business ,Complication ,catecholamines - Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents in some cases with hemostatic and thrombotic complications. Pheochromocytomas are unusual, though potentially lethal tumors. Herein we describe the first case of hemorrhage in a pheochromocytoma related to SARS-CoV-2 infection. A 62-year-old man consulted for syncope, fever, and palpitations. He was diagnosed with SARS-CoV-2 pneumonia and presented with a hemorrhage in a previously unknown adrenal mass, which resulted in a catecholaminergic crisis. Medical treatment and surgery were required for symptom control and stabilization. We hereby alert clinicians to watch for additional/unreported clinical manifestations in COVID-19 infection.
- Published
- 2021